方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| AIMS: 非自主运动量表× | MDS-UPDRS：运动障碍协会（Movement Disorder Society）赞助的帕金森病统一评分量表× | |
|---|---|---|
| 领域 | 神经病学 | 神经病学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1976 | 2008 |
| 提出者≠ | National Institute of Mental Health | Christopher G. Goetz and Movement Disorder Society |
| 类型≠ | Clinician-rated observation | Clinician-rated |
| 开创性文献≠ | National Institute of Mental Health (1976). Abnormal Involuntary Movement Scale (AIMS). In: Rockland, L. H., Schooler, N. R., & Levine, J. (Eds.), Drug Treatment of Mental Disorders. New York: Raven Press. link ↗ | Goetz, C. G., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129-2170. DOI ↗ |
| 别名 | AIMS | UPDRS |
| 相关≠ | 3 | 5 |
| 摘要≠ | The Abnormal Involuntary Movement Scale (AIMS) is the standard clinical rating scale for assessing tardive dyskinesia, a iatrogenic movement disorder resulting from chronic antipsychotic medication exposure. Developed by the National Institute of Mental Health in 1976, the 12-item scale systematically measures involuntary movements across facial, oral, limb, and trunk regions. The AIMS is mandatory screening tool for patients on long-term antipsychotic therapy and essential for monitoring antipsychotic-associated movement complications. | The MDS-UPDRS is the gold-standard clinician-administered rating scale for assessing motor and non-motor manifestations of Parkinson's disease. Developed by the Movement Disorder Society in 2008 to enhance the original UPDRS, it measures disease severity across daily living, motor function, and treatment complications. Used globally in clinical trials, longitudinal cohort studies, and routine neurological practice. |
| ScholarGate数据集 ↗ |
|
|